Cardinal Health Stock Return On Equity
| CLH Stock | EUR 133.30 1.85 1.37% |
Fundamental analysis of Cardinal Health allows traders to better anticipate movements in Cardinal Health's stock price by examining its financial health and performance throughout various phases of its business cycle.
Cardinal |
Cardinal Health Company Return On Equity Analysis
Cardinal Health's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Cardinal Health Return On Equity | -1.71 |
Most of Cardinal Health's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cardinal Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Cardinal Health has a Return On Equity of -1.7132. This is 92.85% lower than that of the Healthcare sector and 123.03% lower than that of the Medical Distribution industry. The return on equity for all Germany stocks is notably higher than that of the company.
Cardinal Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cardinal Health's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cardinal Health could also be used in its relative valuation, which is a method of valuing Cardinal Health by comparing valuation metrics of similar companies.Cardinal Health is currently under evaluation in return on equity category among its peers.
Cardinal Fundamentals
| Return On Equity | -1.71 | |||
| Return On Asset | 0.0223 | |||
| Profit Margin | (0.01) % | |||
| Operating Margin | 0.01 % | |||
| Current Valuation | 20.94 B | |||
| Shares Outstanding | 257.64 M | |||
| Shares Owned By Insiders | 0.39 % | |||
| Shares Owned By Institutions | 90.36 % | |||
| Price To Earning | 10.35 X | |||
| Price To Book | 15.45 X | |||
| Price To Sales | 0.11 X | |||
| Revenue | 181.36 B | |||
| Gross Profit | 6.54 B | |||
| EBITDA | 72 M | |||
| Net Income | (933 M) | |||
| Cash And Equivalents | 3.41 B | |||
| Cash Per Share | 11.73 X | |||
| Total Debt | 4.74 B | |||
| Debt To Equity | 3.74 % | |||
| Current Ratio | 1.12 X | |||
| Book Value Per Share | (8.54) X | |||
| Cash Flow From Operations | 3.12 B | |||
| Earnings Per Share | (4.30) X | |||
| Price To Earnings To Growth | 0.64 X | |||
| Target Price | 57.92 | |||
| Number Of Employees | 45.57 K | |||
| Beta | 0.77 | |||
| Market Capitalization | 18.43 B | |||
| Total Asset | 43.88 B | |||
| Z Score | 5.8 | |||
| Annual Yield | 0.03 % | |||
| Five Year Return | 3.12 % | |||
| Net Asset | 43.88 B | |||
| Last Dividend Paid | 1.98 |
About Cardinal Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cardinal Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cardinal Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cardinal Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| USOI | Credit Suisse X Links | |
| ULTY | Tidal Trust II | |
| CONY | YieldMax N Option | |
| BCAT | BlackRock Capital Allocation | |
| PDI | Pimco Dynamic Income |
Additional Information and Resources on Investing in Cardinal Stock
When determining whether Cardinal Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cardinal Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cardinal Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cardinal Health Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardinal Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Cardinal Stock please use our How to Invest in Cardinal Health guide.You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.